跳至主要内容
临床试验/NCT02583854
NCT02583854已完成不适用

Comparison Study of Compression Devices Used in Transradial Coronary Angiography

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 499 人开始时间: 2015年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
499
试验地点
1
主要终点
Radial artery occlusion

研究概览

简要总结

The transradial route is used in 90% of the coronary angiograms performed at Oslo University Hospital (OUS), Ullevål. A compression device needs to be applied after the procedure to achieve hemostasis. Patients and staff will benefit from using a device that yields safe and painless hemostasis.

Patients will be randomly assigned to receive either the standard compression device (control group, A) or a recently developed compression device (experimental group, B). The study will be designed as a non-inferiority, prospective randomized controlled trial, with outcome measures being patient comfort during compression time and complication rates. Complications that will be measured are radial artery occlusion (RAO) measured using ultrasound at a follow up visit. Hematomas or bleeds from the puncture site after application of the compression device will also be classified as complications.

The aim of the study is to investigate whether the new device, RY-STOP is non-inferior compared to the standard device, when considering the outcome measures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients undergoing coronary angiograms via the transradial route

排除标准

  • Patients who have a long way to travel for the follow up, ultrasound scan
  • Patients that do not understand Norwegian
  • Patients presenting with acute ST segment elevation myocardial infarction (STEMI)

结局指标

主要结局

Radial artery occlusion

时间窗: 90-120 days

Subjects wil have an ultrasound scan of their radial artery preformed after their transradial coronary angiogram to see the rate of occluded arteries.

次要结局

  • Device complications(1-4 hours)
  • Patient experience(1-4 hours)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Anders Opdahl

MD, PhD

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验